You have 9 free searches left this month | for more free features.

Iclusig®

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Jena, Germany
      University Hospital Jena
    Jan 17, 2023

    Iclusig PMS in CML or Ph+ALL Patients

    Recruiting
    • Chronic Myeloid Leukemia
    • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    • Busan, Korea, Republic of
      Kosin University Gaspel Hospital
    Sep 16, 2021

    Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

    Terminated
    • Chronic Phase Chronic Myeloid Leukemia
    • Ponatinib 30 mg QD
    • +2 more
    • Bruxelles, Belgium
      Cliniques Universitaire Saint-Luc (Site 058)
    Oct 28, 2021

    Medullary Thyroid Cancer Trial (Ponatinib)

    Withdrawn
    • Medullary Thyroid Cancer
    • (no location specified)
    Oct 6, 2021

    Leukemia, Myeloid, Acute Trial in France (Ponatinib 30 MG)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Ponatinib 30 MG
    • Angers, France
    • +13 more
    Aug 4, 2021

    Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

    Recruiting
    • Lymphoblastic Leukemia
    • +2 more
    • Inotuzumab ozogamicin
    • +7 more
    • Chicago, Illinois
      University of Chicago Medical Center
    May 16, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)

    Active, not recruiting
    • Chronic Myeloid Leukemia
      • Saint-Pierre, Reunion, France
      • +39 more
      Dec 13, 2021

      Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

      Active, not recruiting
      • Acute Lymphoblastic Leukemia, Adult
      • +2 more
      • Ponatinib 15 MG Oral Tablet
      • Brno, Czechia
      • +6 more
      Nov 30, 2022

      Vascular Occlusive Events Associated With ICLUSIG®

      Terminated
      • Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
        • Hackensack, New Jersey
        • +1 more
        Oct 30, 2020

        Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora

        Completed
        • Adenocarcinoma of the Lung
        • +7 more
        • Aurora, Colorado
          University of Colorado Cancer Center
        Jan 19, 2022

        Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

        Active, not recruiting
        • Leukemia, Myeloid, Chronic-Phase
        • Halle (Saale), Saxony-Anhalt, Germany
        • +9 more
        Sep 9, 2022

        Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

        Active, not recruiting
        • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 2, 2022

        Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)

        Not yet recruiting
        • Chronic Myeloid Leukemia (CML)
        • Ponatinib 15mg QD
        • Ponatinib 30mg QD
        • Cagliari, Italy
        • +12 more
        Jan 31, 2021

        Malignant Tumor Trial in Ann Arbor, Columbus (ponatinib HCl, laboratory biomarker analysis)

        Unknown status
        • Malignant Neoplasm
        • ponatinib hydrochloride
        • laboratory biomarker analysis
        • Ann Arbor, Michigan
        • +1 more
        Feb 14, 2020

        Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in China (Ponatinib)

        Recruiting
        • Chronic Myeloid Leukemia
        • Acute Lymphoblastic Leukemia
        • Hefei, Anhui, China
        • +13 more
        Aug 11, 2020

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic

        Recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 31, 2022

        Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)

        Completed
        • Chronic Myeloid Leukemia
        • Ph+ Acute Lymphoblastic Leukemia
        • St Leonards, New South Wales, Australia
        • +41 more
        Jan 18, 2021

        Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)

        Active, not recruiting
        • Myeloid Leukemia, Chronic, Chronic Phase
        • Atlanta, Georgia
        • +85 more
        Jan 4, 2022

        Ponatinib in BCR-ABL Positive ALL in Standard Clinical Practice

        Withdrawn
        • BCR-ABL Positive Acute Lymphoblastic Leukemia
          • Praha, Czechia
          • +9 more
          Dec 12, 2018

          Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)

          Completed
          • Acute Lymphoblastic Leukemia
          • Acute Myeloid Leukemia
          • Portland, Oregon
            OHSU Knight Cancer Institute
          May 21, 2020

          Glioblastoma Trial in Boston (Ponatinib)

          Completed
          • Glioblastoma
          • Boston, Massachusetts
          • +1 more
          Jun 25, 2018

          Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

          Recruiting
          • Philadelphia Chromosome Positive CML
          • BCR-ABL Positive Chronic Myelogenous Leukemia
          • Amiens, France
          • +27 more
          Dec 9, 2021

          B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in Israel, United States (Blinatumomab,

          Recruiting
          • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
          • Blinatumomab
          • +10 more
          • Anchorage, Alaska
          • +152 more
          Aug 11, 2022